Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R9085 LRM-D | ||
| By: Vasut | H.B. No. 5521 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the possession and administration of an opioid | |
| antagonist by certain entities. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subchapter A, Chapter 773, Health and Safety | |
| Code, is amended by adding Section 773.018 to read as follows: | |
| Sec. 773.018. POSSESSION AND ADMINISTRATION OF OPIOID | |
| ANTAGONIST. (a) In this section, "live music venue" means a | |
| business with a space for live music and a primary revenue source of | |
| patron attendance to live music performances. The term includes a | |
| concert hall and indoor or outdoor stadium. | |
| (b) This section applies to: | |
| (1) an amusement park, as defined by Section 46.03, | |
| Penal Code; | |
| (2) a live music venue; | |
| (3) a sports venue, as defined by Section 504.151, | |
| Local Government Code; and | |
| (4) subject to Subsection (c), other entities the | |
| executive commissioner by rule designates as an entity that | |
| benefits from the possession and administration of opioid | |
| antagonists. | |
| (c) This section does not apply to a governmental entity. | |
| (d) An entity subject to this section may adopt a policy | |
| regarding the maintenance, administration, and disposal of opioid | |
| antagonists. The policy must authorize the administration of an | |
| opioid antagonist for a person reasonably believed to be | |
| experiencing an opioid overdose on the entity's premises only by an | |
| entity employee or volunteer who is authorized and trained to | |
| administer the opioid antagonist. | |
| (e) The executive commissioner shall adopt rules regarding | |
| an entity's maintenance, administration, and disposal of opioid | |
| antagonists under this section. The rules must establish: | |
| (1) the number and dosages of the opioid antagonists | |
| available at each entity; | |
| (2) the process for each entity to regularly verify | |
| its inventory of opioid antagonists for replacement of expired | |
| opioid antagonists; and | |
| (3) the training required for an entity employee or | |
| volunteer to administer an opioid antagonist. | |
| (f) Each entity that adopts a policy under Subsection (d) | |
| must have at least one entity employee or volunteer authorized and | |
| trained to administer an opioid antagonist present during all hours | |
| the entity is open to the public or the population the entity | |
| serves, as applicable. | |
| (g) The entity's supply of opioid antagonists must: | |
| (1) be stored in a secure location and in accordance | |
| with the manufacturer's instructions; and | |
| (2) be easily accessible to an entity employee or | |
| volunteer who is authorized and trained to administer an opioid | |
| antagonist. | |
| (h) Each entity that adopts a policy under Subsection (d) is | |
| responsible for training the entity's employees and volunteers in | |
| the administration of an opioid antagonist. The training must: | |
| (1) include information on: | |
| (A) the signs and symptoms of an opioid overdose; | |
| (B) the recommended opioid antagonist dosages | |
| for an adult and a child; | |
| (C) the administration of an opioid antagonist; | |
| (D) the implementation of any necessary | |
| emergency procedures after administration of an opioid antagonist; | |
| and | |
| (E) the proper disposal of a used or expired | |
| opioid antagonist; and | |
| (2) be completed annually in a formal training session | |
| or through online education. | |
| (i) Each entity shall maintain records on the training | |
| completed by each entity employee and volunteer under this section. | |
| (j) An entity, entity employee or volunteer, or other person | |
| who in good faith acts or fails to act as authorized under this | |
| section, including by administering an opioid antagonist as | |
| authorized in a policy adopted under this section, is immune from | |
| civil or criminal liability or disciplinary action resulting from | |
| that act or failure to act, including: | |
| (1) supervising or delegating the administration of an | |
| opioid antagonist; | |
| (2) possessing, maintaining, storing, or disposing of | |
| an opioid antagonist; | |
| (3) administering, or assisting in the administration | |
| of, an opioid antagonist; | |
| (4) providing training, consultation, or advice in the | |
| development, adoption, or implementation of policies, guidelines, | |
| or plans; or | |
| (5) any other act authorized or required under this | |
| section. | |
| (k) The immunities and protections provided by this section | |
| are in addition to other immunities or limitations of liability | |
| provided by law. | |
| (l) Notwithstanding any other law, this section does not | |
| create a civil, criminal, or administrative cause of action or | |
| liability or create a standard of care, obligation, or duty that | |
| provides a basis for a cause of action for an act or omission under | |
| this section. A cause of action does not arise from an act or | |
| omission described by this section. | |
| (m) An act or failure to act by an entity employee or | |
| volunteer under this section, including an act or failure to act | |
| under related entity policies and procedures, is the exercise of | |
| judgment or discretion on the part of the entity employee or | |
| volunteer and is not considered to be a ministerial act for purposes | |
| of liability of the entity. | |
| SECTION 2. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.